Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 92

1.

Corrigendum to "The impact of sugar-sweetened beverage intake on rat cardiac function" [Heliyon 5 (3) (March 2019) e01357].

Driescher N, Joseph DE, Human VR, Ojuka E, Cour M, Hadebe N, Bester D, Marnewick JL, Lecour S, Lochner A, Essop MF.

Heliyon. 2019 May 14;5(5):e01592. doi: 10.1016/j.heliyon.2019.e01592. eCollection 2019 May.

2.

The impact of sugar-sweetened beverage intake on rat cardiac function.

Driescher N, Joseph DE, Human VR, Ojuka E, Cour M, Hadebe N, Bester D, Marnewick JL, Lecour S, Lochner A, Essop MF.

Heliyon. 2019 Mar 19;5(3):e01357. doi: 10.1016/j.heliyon.2019.e01357. eCollection 2019 Mar. Erratum in: Heliyon. 2019 May 14;5(5):e01592.

3.

HDL Subclass Distribution Shifts with Increasing Central Adiposity.

Woudberg NJ, Lecour S, Goedecke JH.

J Obes. 2019 Feb 3;2019:2107178. doi: 10.1155/2019/2107178. eCollection 2019.

4.

HIV and cardiovascular diseases risk: exploring the interplay between T-cell activation, coagulation, monocyte subsets, and lipid subclass alterations.

Teer E, Joseph DE, Driescher N, Nell TA, Dominick L, Midgley N, Deshpande G, Page MJ, Pretorius E, Woudberg NJ, Lecour S, Glashoff RH, Essop MF.

Am J Physiol Heart Circ Physiol. 2019 May 1;316(5):H1146-H1157. doi: 10.1152/ajpheart.00797.2018. Epub 2019 Feb 15.

PMID:
30768357
5.

ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure.

Madonna R, Van Laake LW, Botker HE, Davidson SM, De Caterina R, Engel FB, Eschenhagen T, Fernandez-Aviles F, Hausenloy DJ, Hulot JS, Lecour S, Leor J, Menasché P, Pesce M, Perrino C, Prunier F, Van Linthout S, Ytrehus K, Zimmermann WH, Ferdinandy P, Sluijter JPG.

Cardiovasc Res. 2019 Mar 1;115(3):488-500. doi: 10.1093/cvr/cvz010.

PMID:
30657875
6.

The 10th Biennial Hatter Cardiovascular Institute workshop: cellular protection-evaluating new directions in the setting of myocardial infarction, ischaemic stroke, and cardio-oncology.

Davidson SM, Arjun S, Basalay MV, Bell RM, Bromage DI, Bøtker HE, Carr RD, Cunningham J, Ghosh AK, Heusch G, Ibanez B, Kleinbongard P, Lecour S, Maddock H, Ovize M, Walker M, Wiart M, Yellon DM.

Basic Res Cardiol. 2018 Oct 11;113(6):43. doi: 10.1007/s00395-018-0704-z.

7.

Exercise intervention alters HDL subclass distribution and function in obese women.

Woudberg NJ, Mendham AE, Katz AA, Goedecke JH, Lecour S.

Lipids Health Dis. 2018 Oct 10;17(1):232. doi: 10.1186/s12944-018-0879-1.

8.

Cardiovascular Benefits of Dietary Melatonin: A Myth or a Reality?

Jiki Z, Lecour S, Nduhirabandi F.

Front Physiol. 2018 May 17;9:528. doi: 10.3389/fphys.2018.00528. eCollection 2018. Review.

9.

Vasculature on the clock: Circadian rhythm and vascular dysfunction.

Crnko S, Cour M, Van Laake LW, Lecour S.

Vascul Pharmacol. 2018 Sep;108:1-7. doi: 10.1016/j.vph.2018.05.003. Epub 2018 May 17. Review.

PMID:
29778521
10.

An Exercise Intervention to Unravel the Mechanisms Underlying Insulin Resistance in a Cohort of Black South African Women: Protocol for a Randomized Controlled Trial and Baseline Characteristics of Participants.

Goedecke JH, Mendham AE, Clamp L, Nono Nankam PA, Fortuin-de Smidt MC, Phiri L, Micklesfield LK, Keswell D, Woudberg NJ, Lecour S, Alhamud A, Kaba M, Lutomia FM, van Jaarsveld PJ, de Villiers A, Kahn SE, Chorell E, Hauksson J, Olsson T.

JMIR Res Protoc. 2018 Apr 18;7(4):e75. doi: 10.2196/resprot.9098.

11.

Pharmacological Intervention to Modulate HDL: What Do We Target?

Woudberg NJ, Pedretti S, Lecour S, Schulz R, Vuilleumier N, James RW, Frias MA.

Front Pharmacol. 2018 Jan 22;8:989. doi: 10.3389/fphar.2017.00989. eCollection 2017. Review.

12.

Sphingosine-1-phosphate (S1P) activates STAT3 to protect against de novo acute heart failure (AHF).

Deshpande GP, Imamdin A, Lecour S, Opie LH.

Life Sci. 2018 Mar 1;196:127-132. doi: 10.1016/j.lfs.2018.01.023. Epub 2018 Jan 31.

PMID:
29373815
13.

The SAFE pathway for cardioprotection: is this a promising target?

Hadebe N, Cour M, Lecour S.

Basic Res Cardiol. 2018 Jan 15;113(2):9. doi: 10.1007/s00395-018-0670-5. Review.

PMID:
29335904
14.

Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology.

Sluijter JPG, Davidson SM, Boulanger CM, Buzás EI, de Kleijn DPV, Engel FB, Giricz Z, Hausenloy DJ, Kishore R, Lecour S, Leor J, Madonna R, Perrino C, Prunier F, Sahoo S, Schiffelers RM, Schulz R, Van Laake LW, Ytrehus K, Ferdinandy P.

Cardiovasc Res. 2018 Jan 1;114(1):19-34. doi: 10.1093/cvr/cvx211. Review.

15.

Soluble ST2 correlates with some indicators of right ventricular function in hypertensive heart failure.

Ojji DB, Lecour S, Adeyemi OM, Sliwa K.

Vasc Health Risk Manag. 2017 Aug 16;13:311-316. doi: 10.2147/VHRM.S127430. eCollection 2017.

16.

Melatonin as a cardioprotective therapy following ST-segment elevation myocardial infarction: is it really promising? Reply.

Hausenloy DJ, Garcia-Dorado D, Erik Bøtker H, Davidson SM, Downey J, Engel FB, Jennings R, Lecour S, Leor J, Madonna R, Ovize M, Perrino C, Prunier F, Schulz R, Sluijter JPG, Van Laake LW, Vinten-Johansen J, Yellon DM, Ytrehus K, Heusch G, Ferdinandy P.

Cardiovasc Res. 2017 Sep 1;113(11):1418-1419. doi: 10.1093/cvr/cvx137. No abstract available.

PMID:
28859295
17.

Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.

Perrino C, Barabási AL, Condorelli G, Davidson SM, De Windt L, Dimmeler S, Engel FB, Hausenloy DJ, Hill JA, Van Laake LW, Lecour S, Leor J, Madonna R, Mayr M, Prunier F, Sluijter JPG, Schulz R, Thum T, Ytrehus K, Ferdinandy P.

Cardiovasc Res. 2017 Jun 1;113(7):725-736. doi: 10.1093/cvr/cvx070. Review.

18.

Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.

Hausenloy DJ, Garcia-Dorado D, Bøtker HE, Davidson SM, Downey J, Engel FB, Jennings R, Lecour S, Leor J, Madonna R, Ovize M, Perrino C, Prunier F, Schulz R, Sluijter JPG, Van Laake LW, Vinten-Johansen J, Yellon DM, Ytrehus K, Heusch G, Ferdinandy P.

Cardiovasc Res. 2017 May 1;113(6):564-585. doi: 10.1093/cvr/cvx049. Review.

PMID:
28453734
19.

Novel putative pharmacological therapies to protect the right ventricle in pulmonary hypertension: a review of current literature.

Maarman GJ, Schulz R, Sliwa K, Schermuly RT, Lecour S.

Br J Pharmacol. 2017 Apr;174(7):497-511. doi: 10.1111/bph.13721. Epub 2017 Feb 24. Review.

20.

Cardiology-cardiothoracic subspeciality training in South Africa: a position paper of the South Africa Heart Association.

Sliwa K, Zühlke L, Kleinloog R, Doubell A, Ebrahim I, Essop M, Kettles D, Jankelow D, Khan S, Klug E, Lecour S, Marais D, Mpe M, Ntsekhe M, Osrin L, Smit F, Snyders A, Theron JP, Thornton A, Chin A, van der Merwe N, Dau E, Sarkin A.

Cardiovasc J Afr. 2016 May/Jun;27(3):188-193. doi: 10.5830/CVJA-2016-063.

Supplemental Content

Loading ...
Support Center